№ lp_2_1_00833
File format: docx
Character count: 3254
File size: 16 KB
Supplementary Table 1 provides a characterization of various endometrial cancer cell lines, including details on differentiation, estrogen receptors, and progesterone receptors.
Year:
n.d.
Region / city:
n.d.
Topic:
Cancer research
Document type:
Supplementary table
Organization / institution:
n.d.
Author:
n.d.
Target audience:
Researchers, medical professionals
Effective period:
n.d.
Approval date:
n.d.
Amendment date:
n.d.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / city:
Global
Theme:
Oncology, Endometrial Cancer, Pharmaceutical Submissions
Document Type:
Medical Submission
Organization / Institution:
AstraZeneca Pty Ltd
Author:
AstraZeneca Pty Ltd
Target Audience:
Medical professionals, regulatory bodies, pharmaceutical companies
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2022
Country:
Australia
Therapeutic area:
Oncology
Disease:
Endometrial cancer
Biomarker status:
Mismatch repair deficient (dMMR)
Medicine name:
Dostarlimab
Brand name:
Jemperli
Dosage form:
Solution concentrate for intravenous infusion
Sponsor:
GlaxoSmithKline Australia Pty Ltd
Regulatory body:
Pharmaceutical Benefits Advisory Committee
Submission type:
Standard Re-entry submission
Requested listing:
Section 100
Comparator treatments:
Standard of care chemotherapy; pembrolizumab plus lenvatinib; pembrolizumab monotherapy
Clinical trial referenced:
GARNET
Approval status:
Provisional approval
Indication:
Recurrent or advanced endometrial cancer after platinum-containing regimen
Decision context:
PBS listing consideration
Period covered:
Up to November 2022
Year:
2019
Month:
January
Organisation:
British Gynaecological Cancer Society (BGCS)
Region:
United Kingdom
Field:
Gynaecological Oncology
Topic:
Sentinel Lymph Node Technique in Vulval, Cervical and Endometrial Cancer
Document Type:
Consensus Statement
Authors:
Christina Fotopoulou; Thomas Ind; Peter Baldwin; Robin Crawford; Omer Devaja; Stephen Dobbs; Jonathan Frost; Ketan Gajjar; Raji Ganesan; Sonali Kaushik; Jo Morrison; Marielle Nobbenhuis; Nithya Ratnavelu; Phil Rolland; Naveena Singh; Alexandra Taylor; Sudha Sundar; Andy Nordin
Participating Body:
BGCS officers and expert members of the UK gynaecological oncological community
Methodology:
Delphi process with two rounds and 80% consensus threshold
Scope:
Applicability, oncologic safety and surgical safety of sentinel lymph node algorithms
Cancers Addressed:
Vulval cancer; Cervical cancer; Endometrial cancer
Guidelines Considered:
European Society of Gynaecological Oncologists (ESGO)
Implementation Context:
UK gynaecological cancer centres
Clinical Focus:
Surgical staging; SLN mapping; Lymphadenectomy; Histological ultra-staging; Training and audit requirements
Year:
2023
Region / City:
N/A
Subject:
Endometrial Cancer Surgery Accreditation
Document Type:
Application Form
Organization / Institution:
ESGO
Author:
N/A
Target Audience:
Medical centers, healthcare professionals
Period of validity:
N/A
Approval Date:
N/A
Date of changes:
N/A
Year:
2026
Region / City:
Not specified
Subject:
Molecular and cellular analysis of endometrial cancer
Document Type:
Supplementary figures
Institution:
Not specified
Authors:
Not specified
Target Audience:
Researchers in oncology and molecular biology
Study Period:
Not specified
Data Sources:
Human endometrial cancer patients, cancer cell lines, mouse endometrial tissues, TCGA database
Methods:
Immunohistochemistry, immunofluorescence, ChIP-seq, RT-qPCR, AFM
Measured Parameters:
Gene expression, cell migration, apoptosis, cytoskeleton content, adhesion force
Statistical Significance Indicators:
* P<0.05, ** P<0.01, *** P<0.005, **** P<0.001
Year:
2017-2018
Region / city:
Doncaster
Subject:
Gynaecology, Endometrial Biopsy
Document Type:
Service Specification
Organization:
NHS Doncaster CCG
Author:
Not specified
Target Audience:
Healthcare providers, GPs
Effective Period:
1st April 2017 to 31st March 2018
Approval Date:
Not specified
Date of Last Review:
Annual
Changes Date:
Not specified
Year:
2012
Region / City:
United States
Theme:
Social science, health, finance, business ownership
Document Type:
Survey instrument
Agency / Organization:
Bureau of Labor Statistics (BLS)
Author:
Not specified
Target Audience:
Researchers, policymakers, survey respondents
Period of validity:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2020
Region / City:
Riyadh
Subject:
Computer Engineering
Document Type:
Dissertation
Institution:
King Saud University
Author:
First name Last name
Target Audience:
Academic/Research Community
Period of Validity:
N/A
Approval Date:
March, 2020
Date of Modifications:
N/A
Year:
2021
Region / City:
West Virginia
Theme:
Insurance, Tax Reporting
Document Type:
Instructions, Form Filling Guidelines
Organization / Institution:
West Virginia Offices of the Insurance Commissioner
Author:
West Virginia Offices of the Insurance Commissioner
Target Audience:
Insurance Licensees, Surplus Lines Agents
Effective Period:
From July 1, 2011
Approval Date:
2011-07-01
Date of Changes:
Not specified
Context:
Detailed guidelines for filling out the Annual Surplus Lines Tax Return and related forms for insurance policy reporting and tax reconciliation.
Year:
2014
Region / City:
United States
Topic:
Social Science / Survey Design
Document Type:
Research Report
Institution:
Bureau of Labor Statistics (BLS)
Author:
Bureau of Labor Statistics
Target Audience:
Researchers in social science, policy makers
Effective Period:
2014
Approval Date:
2014
Revision Date:
Not specified
Year:
2025
Region / City:
Milimani, Nairobi
Subject:
Commercial & Tax Court Communications
Document Type:
Official Communication
Authority:
High Court of Kenya
Author:
Commercial & Tax Division Bar Bench Committee
Target Audience:
Court users, legal practitioners, and other stakeholders
Effective Period:
February 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
East Asia-Pacific
Topic:
Structural Engineering, Sustainability
Document Type:
Conference Paper
Author:
Firstnameone Lastnameone, Firstnametwo Lastnametwo, Firstnamethree Lastnamethree
Target Audience:
Engineers, Researchers
Action Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Topic:
Creative Writing & Literature
Document type:
Thesis
Institution:
Harvard University
Author:
Author’s Name
Target audience:
Graduate students, researchers
Title of Report in Initial Capital Letters: Arial (24 points, Boldface) and No More Than Three Lines
Note:
Year
Year:
2022
Region / City:
New South Wales
Subject:
Mathematics
Document Type:
Educational Activity Plan
Organization / Institution:
NSW Education Standards Authority (NESA)
Author:
Not specified
Target Audience:
Students
Validity Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Topic:
Computer Science
Document Type:
Thesis
Institution:
Weber State University
Author:
[Author’s Name]
Target Audience:
Graduate students, researchers in Computer Science
Year:
Not specified
Organization:
Department of Energy or affiliated office
Document type:
Evaluation criteria and review approach
Scope:
Quality assurance program implementation
Topics:
Program organization, personnel training and qualification, quality improvement, documents and records, work processes, design
Target audience:
QA reviewers and program managers
Reference:
DOE O 414.1D
Document structure:
Criteria and lines of inquiry